Skip to main content
. 2019 Oct 24;49(5):250–257. doi: 10.4274/tjo.galenos.2019.81594

Figure 1.

Figure 1

Distribution of the patients’ vitreous haze scores before and at 1, 3, and 6 months after the first intravitreal dexamethasone implant injection. Vitreous haze decreased markedly in the first 3 months and this effect persisted to 6 months

DEX: Dexamethasone